Carregant...
Why Targeting HDL Should Work as a Therapeutic Tool, but Hasn’t
Atherosclerosis is one of the most common causes of death and disability in US today despite the availability of statins which reduce hyperlipidemia, a risk factor that predisposes individuals to this disease. Epidemiology of human populations has overwhelmingly demonstrated an inverse correlation b...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3772973/ https://ncbi.nlm.nih.gov/pubmed/23743767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0b013e31829d48a5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|